Latest Oseltamivir Stories
Global Phase 3 Clinical Trial to Study NT-300 for Treatment of Acute Uncomplicated Influenza TAMPA, Fla., April 18, 2013 /PRNewswire/ -- Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza. (Logo: http://photos.prnewswire.com/prnh/20100201/FL47022LOGO ) The Phase 3 clinical trial has been initiated in the United States, will continue in Australia and New...
Brett Smith for redOrbit.com – Your Universe Online By analyzing sewage, a group of European researchers was able to determine that about half of the Tamiflu prescribed during the 2009-2010 influenza pandemic went unused in England. The team’s findings, which were published in the open access journal PLOS ONE, could be used to inform the next pandemic reaction by health officials and served as validation for the novel method used to measure widespread prescription drug compliance....
New assays are a powerful tool for enhanced influenza virus surveillance, say researchers in The Journal of Molecular Diagnostics Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly. Scientists in the Netherlands have designed and evaluated a set of molecular assays...
Kwiksure provides information about the recent cases of new flu virus in China and discusses the benefits of a private health insurance plan during a possible flu outbreak. Hong Kong (PRWEB) April 15, 2013 Last month, a new strain of flu virus, H7N9, was reported in China. Since then, 60 individuals have been diagnosed and 13 deaths have been reported in the region. Hong Kong experienced its own scare when a seven year old fell ill after coming back from Shanghai, however, the child...
$44 Million Contract with U.S. Department of Health and Human Services to Fund Completion of Clinical Development and Preparation for Submission of New Drug Application for NT-300 TAMPA, Fla., Feb. 28, 2013 /PRNewswire/ -- Romark Laboratories has been awarded a contract with the U.S. Department of Health and Human Services (HHS) to complete the advanced development of NT-300 (nitazoxanide) as a treatment of acute uncomplicated influenza. The value of the cost plus fixed-fee contract...
redOrbit Staff & Wire Reports – Your Universe Online In their continuing battle against substances falsely claiming to be able to help treat or cure the flu, the U.S. Food and Drug Administration (FDA) is now targeting producers of dietary supplements and medicines claiming to be generic versions of drugs that have been approved by regulators. According to Reuters reporter Toni Clarke, the FDA sent letters to nine online supplement distributors warning them about making...
Tamiflu is a drug used to treat the flu; it is not a vaccine OTTAWA, Jan. 8, 2013 /CNW/ - The Government of Canada is working with Roche Canada and the provincial and territorial health authorities to address a potential temporary shortage of the antiviral flu drug oseltamivir (Tamiflu). The Public Health Agency of Canada and Health Canada are arranging to immediately release a supply of the drug Tamiflu from the Agency's National Emergency Stockpile System to the manufacturer...
redOrbit Staff & Wire Reports - Your Universe Online An antiviral medication that can chemically slow the spread of influenza virus between the body's cells, has been approved by the US Food and Drug Administration (FDA) for use in infants as young as 14 days old, the agency announced on Friday. According to Reuters, the agency declared the prescription drug Tamiflu, which is also known as oseltamivir phosphate, cannot be used to prevent flu infection in that age group, but it can...
Analysis of hospital data highlights potential benefits of antiviral treatment in a hospital setting BOSTON, Nov. 5, 2012 /PRNewswire-USNewswire/ -- Children hospitalized for the flu are much less likely to require breathing support from a mechanical ventilator if they receive antiviral drugs like oseltamivir (Tamiflu®) as soon as possible after admission, according to researchers at Boston Children's Hospital. The findings, based on an analysis of pediatric hospital data...
MIAMI, Sept. 10, 2012 /PRNewswire/ -- Nuovo Biologics, LLC announced that Robert G. Savage has joined its Board. Mr. Savage served as Group Vice President and President - General Therapeutics & Inflammation Business of Pharmacia Corporation from 2002 until its acquisition by Pfizer, Inc. in 2003. From 1996 through 2001, Mr. Savage served Johnson & Johnson in a variety of roles, most recently as Worldwide Chairman of Johnson and Johnson's Pharmaceutical Group. From 1985 to...
